Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
randomized double-blind controlled study in parallel groups
Salbutamol is a β2 mimetic short-acting to be administered by nebulization in this study.
During this administration, non invasive ventilation for the patient will be continued.